PCML
MRK icon

Pavaki Capital Management LLC’s Merck MRK Stock Holding History

Pavaki Capital Management LLC’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$643K Hold
5,000
– – 0.22% 77
2026
Q1 		$601K Hold
5,000
– – 0.26% 66
2025
Q4 		$526K Buy
+5,000
New +$469K 0.21% 63

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Pavaki Capital Management LLC's MRK Position: Q2 2026 in Review

Pavaki Capital Management LLC held its Merck (MRK) position steady in Q2 2026 at 5,000 shares worth $643K. The position accounts for 0.22% of the portfolio, ranked #77.

Pavaki Capital Management LLC first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 2,532 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Pavaki Capital Management LLC held 5,000 shares of Merck worth $643K as of Q2 2026.
  • Pavaki Capital Management LLC left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.22% of Pavaki Capital Management LLC's portfolio in Q2 2026, its #77 holding.
  • Pavaki Capital Management LLC first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • 2,532 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Pavaki Capital Management LLC's 13F filing for Q2 2026, filed 7 Aug 2026.